Selpercatinib in

• Tác giả: Scott Barker, Filippo De Braud, Alexander Drilon, Bente Frimodt-Moller, Oliver Gautschi, Koichi Goto, Katherine Liming, Herbert H Loong, Geoffrey R Oxnard, Keunchil Park, Patrick Peterson, Benjamin J Solomon, Pascale Tomasini
• Ngôn ngữ: eng
• Thông tin xuất bản: United States : Journal of clinical oncology : official journal of the American Society of Clinical Oncology , 2025
• Bộ sưu tập: NCBI
• ID: 473714

Tóm tắt

LIBRETTO-001 (ClinicalTrials.gov identifier: NCT03157128) is a registrational phase I/II, single-arm, open-label trial of selpercatinib in RET-dependent cancers. With 19 months of additional follow-up, we report the final efficacy and safety results of selpercatinib in patients with